Side-by-side comparison of AI visibility scores, market position, and capabilities
Kenvue-owned lactose-free dairy brand with enzyme-treated real milk and ice cream; leading lactase-treated dairy competing with Fairlife and plant-based alternatives for lactose-intolerant consumers.
Lactaid is the leading lactose-free dairy brand, producing milk, ice cream, cottage cheese, and cream products that are treated with lactase enzyme to pre-digest the lactose — allowing the estimated 36% of Americans who are lactose intolerant to enjoy real dairy products without gastrointestinal symptoms. Lactaid is owned by McNeil Nutritionals, a subsidiary of Johnson & Johnson (NYSE: JNJ), though J&J has divested various consumer health assets over the years; the Lactaid brand is now part of the consumer health spinoff Kenvue (NYSE: KVUE).\n\nLactaid's products are made with real cow's milk that undergoes lactase enzyme treatment to break down lactose into simpler sugars (glucose and galactose) that lactose-intolerant individuals can digest without discomfort. The resulting products taste like regular dairy (the additional simple sugars may make the milk slightly sweeter) but are tolerated by those who lack sufficient lactase enzyme production. The Lactaid milk line includes whole, 2%, 1%, fat-free, and calcium-enriched varieties, with the ice cream line as an important premium revenue driver.\n\nIn 2025, Lactaid competes with Fairlife (Coca-Cola, ultra-filtered lactose-free milk), private label lactose-free milk from Horizon Organic (Danone), and plant-based milk alternatives (oat milk, almond milk) that lactose-intolerant consumers may choose instead. Lactaid's brand positioning as real dairy (unlike plant-based alternatives) and its established retail distribution give it a defensible position among lactose-intolerant consumers who prefer dairy taste and nutrition. Kenvue's ownership (post-J&J consumer health spinoff in 2023) provides a dedicated consumer health focus. The 2025 strategy focuses on growing the premium ice cream segment, maintaining retail distribution leadership, and reinforcing the "real dairy, no discomfort" positioning that differentiates Lactaid from both plant-based alternatives and generic lactase supplements.
NASDAQ: SBUX global coffeehouse at $37.184B revenue FY2025 with 40,199 stores and 33.8M Rewards members; CEO Niccol 'Back to Starbucks' operational turnaround competing with Dunkin' and Dutch Bros for premium coffee occasions.
Starbucks Corporation is a Seattle, Washington-based global coffeehouse chain — listed on NASDAQ (NASDAQ: SBUX) — operating 40,199 stores in 88 countries as of fiscal year 2025, serving 100 million customers weekly (14.3 million daily) through company-operated and licensed locations that offer espresso beverages, premium coffee, teas, food items, and merchandise, generating $37.184 billion in revenue in fiscal year 2025 (+2.79% year-over-year) with 33.8 million US Starbucks Rewards members (+4%) and positive comparable store sales growth in Q4 FY2025 after seven consecutive quarters of negative or flat comps under prior leadership. Founded in 1971 in Seattle's Pike Place Market and transformed into the global third-place coffeehouse experience by Howard Schultz, Starbucks holds 40.88% food service market share in the US coffee category.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.